BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33611029)

  • 1. Clinical characteristics and treatment analysis of pancreatic acinar cell carcinoma: A single institutional comparison to pancreatic ductal adenocarcinoma.
    Huang X; Li M; Zhang L; Xiong J; Lu H; Tian B
    Surg Oncol; 2021 Jun; 37():101528. PubMed ID: 33611029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma.
    Schmidt CM; Matos JM; Bentrem DJ; Talamonti MS; Lillemoe KD; Bilimoria KY
    J Gastrointest Surg; 2008 Dec; 12(12):2078-86. PubMed ID: 18836784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and surgical outcomes of resectable acinar cell carcinoma of the pancreas-propensity score matching analysis with pancreatic ductal adenocarcinoma.
    Chen H; Xu Z; Shen Z; Weng Y; Wang W; Ying X; Wang X; Deng X; Shen B
    Eur J Surg Oncol; 2022 May; 48(5):1062-1067. PubMed ID: 34887166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical resection of hepatic and rectal metastases of pancreatic acinar cell carcinoma (PACC): a case report.
    Ohara Y; Oda T; Enomoto T; Hisakura K; Akashi Y; Ogawa K; Owada Y; Domoto Y; Miyazaki Y; Shimomura O; Kurata M; Ohkohchi N
    World J Surg Oncol; 2018 Aug; 16(1):158. PubMed ID: 30075727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC.
    Florou V; Elliott A; Bailey MH; Stone D; Affolter K; Soares HP; Nevala-Plagemann C; Scaife C; Walker P; Korn WM; Lou E; Shroff RT; Hosein PJ; Garrido-Laguna I
    Clin Cancer Res; 2023 Sep; 29(17):3408-3417. PubMed ID: 37266563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival Outcome and Prognostic Factors for Pancreatic Acinar Cell Carcinoma: Retrospective Analysis from the German Cancer Registry Group.
    Petrova E; Wellner J; Nording AK; Braun R; Honselmann KC; Bolm L; Hummel R; Klinkhammer-Schalke M; Zeissig SR; Kleihues van Tol K; Timme-Bronsert S; Bronsert P; Zemskov S; Keck T; Wellner UF
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection.
    Gablo N. A; Procházka V; Hlavsa J; Kiss I; Srovnal J; Kala Z; Slabý O
    Klin Onkol; 2019; 32(Suppl 1):174-176. PubMed ID: 31064193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular resection for locally advanced pancreatic ductal adenocarcinoma: analysis of long-term outcomes from a single-centre series.
    Feo CF; Deiana G; Ninniri C; Cherchi G; Crivelli P; Fancellu A; Ginesu GC; Porcu A
    World J Surg Oncol; 2021 Apr; 19(1):126. PubMed ID: 33866970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural History and Treatment Trends in Pancreatic Cancer Subtypes.
    Pokrzywa CJ; Abbott DE; Matkowskyj KA; Ronnekleiv-Kelly SM; Winslow ER; Weber SM; Fisher AV
    J Gastrointest Surg; 2019 Apr; 23(4):768-778. PubMed ID: 30706376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomorphologic, immunophenotypical and molecular features of pancreatic acinar cell carcinoma.
    Sun T; Gilani S; Jain D; Cai G
    Diagn Cytopathol; 2023 Nov; 51(11):674-683. PubMed ID: 37469257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics of invasive ductal carcinomas of the pancreas according to the histological differentiation].
    Yamaue H
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():48-51. PubMed ID: 16457220
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness of minimally invasive surgery in the treatment of pancreatic acinar cell carcinoma].
    Tao M; Yuan CH; Ma CL; Jiang B; Li L; Wang HY; Xiu DR
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(12):950-955. PubMed ID: 38514344
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical presentation and prognosis of adenosquamous carcinoma of the pancreas - Matched-pair analysis with pancreatic ductal adenocarcinoma.
    Kaiser J; Hinz U; Mayer P; Hank T; Niesen W; Hackert T; Gaida MM; Büchler MW; Strobel O
    Eur J Surg Oncol; 2021 Jul; 47(7):1734-1741. PubMed ID: 33622577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma.
    Gao Y; Wang M; Guo X; Hu J; Chen TM; Finn SMB; Lacy J; Kunstman JW; Cha CH; Bellin MD; Robert ME; Desir GV; Gorelick FS
    PLoS One; 2021; 16(9):e0250539. PubMed ID: 34587190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
    Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
    J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics of Resected Acinar Cell Carcinoma of the Pancreas: A Korean Multi-Institutional Study.
    Shin SH; Hwang HK; Jang JY; Kim H; Park SJ; Han SS; Han IW; Hwang DW; Heo JS
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with hepatic oligometastatic pancreatic body/tail ductal adenocarcinoma may benefit from synchronous resection.
    Yang J; Zhang J; Lui W; Huo Y; Fu X; Yang M; Hua R; Wang L; Sun Y
    HPB (Oxford); 2020 Jan; 22(1):91-101. PubMed ID: 31262486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors for abdominal occult metastatic disease in patients with pancreatic adenocarcinoma.
    Gemenetzis G; Groot VP; Blair AB; Ding D; Thakker SS; Fishman EK; Cameron JL; Makary MA; Weiss MJ; Wolfgang CL; He J
    J Surg Oncol; 2018 Dec; 118(8):1277-1284. PubMed ID: 30380143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse Oncologic Impact of New-Onset Diabetes Mellitus on Recurrence in Resected Pancreatic Ductal Adenocarcinoma: A Comparison With Long-standing and Non-Diabetes Mellitus Patients.
    Lee S; Hwang HK; Kang CM; Lee WJ
    Pancreas; 2018 Aug; 47(7):816-822. PubMed ID: 29975349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.